Onconetix CBO Erin Henderson resigns, will consult for 3 months

Onconetix, Inc.

Erin Henderson resigned as Chief Business Officer effective December 21, 2023.
Separation and consulting agreements being finalized; consulting term of 3 months.
Henderson left to pursue other opportunities.
Company ticker BWV; no new officer announced.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Erin Henderson

Chief Business Officer

ONCO · Onconetix, Inc.

Effective: 2023-12-21
Filed: December 28, 2023, 6:59 PM ET

On and effective December 21, 2023, Erin Henderson resigned as Chief Business Officer of Onconetix, Inc. (the “Company”) to pursue other opportunities.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Erin Henderson resigned as Chief Business Officer at Onconetix, Inc..

Action: resigned
Role: Chief Business Officer

Exact text from the filing

On and effective December 21, 2023, Erin Henderson resigned as Chief Business Officer of Onconetix, Inc. (the “Company”) to pursue other opportunities.

View on SEC.gov

Onconetix, Inc. filing history →

Source: SEC EDGAR

accession 0001213900-23-099224

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.